nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—Thiotepa—urinary bladder cancer	0.216	0.401	CbGbCtD
Pethidine—ALB—Fluorouracil—urinary bladder cancer	0.0688	0.128	CbGbCtD
Pethidine—CYP3A4—Thiotepa—urinary bladder cancer	0.0664	0.123	CbGbCtD
Pethidine—CYP2B6—Cisplatin—urinary bladder cancer	0.0596	0.111	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—urinary bladder cancer	0.04	0.0742	CbGbCtD
Pethidine—ALB—Methotrexate—urinary bladder cancer	0.0379	0.0705	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0193	0.0358	CbGbCtD
Pethidine—CYP3A4—Etoposide—urinary bladder cancer	0.018	0.0334	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0123	0.0228	CbGbCtD
Pethidine—GRIN2D—prostate gland—urinary bladder cancer	0.00386	0.149	CbGeAlD
Pethidine—CYP2C19—urine—urinary bladder cancer	0.00335	0.13	CbGeAlD
Pethidine—OPRK1—prostate gland—urinary bladder cancer	0.00245	0.0949	CbGeAlD
Pethidine—CYP3A4—urine—urinary bladder cancer	0.00198	0.0766	CbGeAlD
Pethidine—CYP2D6—urine—urinary bladder cancer	0.00195	0.0754	CbGeAlD
Pethidine—ORM1—prostate gland—urinary bladder cancer	0.0017	0.0659	CbGeAlD
Pethidine—GRIN2A—vagina—urinary bladder cancer	0.00142	0.0548	CbGeAlD
Pethidine—OPRK1—female reproductive system—urinary bladder cancer	0.00134	0.0518	CbGeAlD
Pethidine—Cardiac arrest—Etoposide—urinary bladder cancer	0.00113	0.00377	CcSEcCtD
Pethidine—Injection site pain—Epirubicin—urinary bladder cancer	0.00113	0.00375	CcSEcCtD
Pethidine—Dizziness—Mitomycin—urinary bladder cancer	0.00107	0.00357	CcSEcCtD
Pethidine—Delirium—Epirubicin—urinary bladder cancer	0.00107	0.00356	CcSEcCtD
Pethidine—Vasodilation—Epirubicin—urinary bladder cancer	0.00105	0.00348	CcSEcCtD
Pethidine—Vasodilation procedure—Epirubicin—urinary bladder cancer	0.00105	0.00348	CcSEcCtD
Pethidine—Injection site pain—Doxorubicin—urinary bladder cancer	0.00104	0.00347	CcSEcCtD
Pethidine—Sweating—Gemcitabine—urinary bladder cancer	0.00103	0.00343	CcSEcCtD
Pethidine—Vomiting—Mitomycin—urinary bladder cancer	0.00103	0.00343	CcSEcCtD
Pethidine—Rash—Mitomycin—urinary bladder cancer	0.00102	0.0034	CcSEcCtD
Pethidine—Dermatitis—Mitomycin—urinary bladder cancer	0.00102	0.0034	CcSEcCtD
Pethidine—Headache—Mitomycin—urinary bladder cancer	0.00102	0.00338	CcSEcCtD
Pethidine—Erythema—Thiotepa—urinary bladder cancer	0.000999	0.00332	CcSEcCtD
Pethidine—Delirium—Doxorubicin—urinary bladder cancer	0.00099	0.00329	CcSEcCtD
Pethidine—Dyskinesia—Epirubicin—urinary bladder cancer	0.000979	0.00326	CcSEcCtD
Pethidine—Vasodilation—Doxorubicin—urinary bladder cancer	0.000969	0.00322	CcSEcCtD
Pethidine—Vasodilation procedure—Doxorubicin—urinary bladder cancer	0.000969	0.00322	CcSEcCtD
Pethidine—Nausea—Mitomycin—urinary bladder cancer	0.000963	0.0032	CcSEcCtD
Pethidine—Depressed level of consciousness—Methotrexate—urinary bladder cancer	0.000949	0.00316	CcSEcCtD
Pethidine—Coordination abnormal—Epirubicin—urinary bladder cancer	0.000937	0.00312	CcSEcCtD
Pethidine—ORM1—female reproductive system—urinary bladder cancer	0.000929	0.036	CbGeAlD
Pethidine—Agitation—Thiotepa—urinary bladder cancer	0.000918	0.00305	CcSEcCtD
Pethidine—Bradycardia—Cisplatin—urinary bladder cancer	0.000916	0.00305	CcSEcCtD
Pethidine—Dyskinesia—Doxorubicin—urinary bladder cancer	0.000906	0.00301	CcSEcCtD
Pethidine—Coma—Methotrexate—urinary bladder cancer	0.000899	0.00299	CcSEcCtD
Pethidine—Visual impairment—Cisplatin—urinary bladder cancer	0.000867	0.00288	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—urinary bladder cancer	0.000867	0.00288	CcSEcCtD
Pethidine—Convulsion—Thiotepa—urinary bladder cancer	0.000866	0.00288	CcSEcCtD
Pethidine—Hypertension—Thiotepa—urinary bladder cancer	0.000863	0.00287	CcSEcCtD
Pethidine—Anxiety—Thiotepa—urinary bladder cancer	0.000848	0.00282	CcSEcCtD
Pethidine—Coma—Epirubicin—urinary bladder cancer	0.000841	0.0028	CcSEcCtD
Pethidine—Erythema—Gemcitabine—urinary bladder cancer	0.00084	0.0028	CcSEcCtD
Pethidine—Flushing—Cisplatin—urinary bladder cancer	0.000835	0.00278	CcSEcCtD
Pethidine—Erythema—Fluorouracil—urinary bladder cancer	0.000826	0.00275	CcSEcCtD
Pethidine—Confusional state—Thiotepa—urinary bladder cancer	0.000822	0.00273	CcSEcCtD
Pethidine—Tachycardia—Thiotepa—urinary bladder cancer	0.000796	0.00265	CcSEcCtD
Pethidine—SLC6A4—female reproductive system—urinary bladder cancer	0.000792	0.0306	CbGeAlD
Pethidine—Erythema—Cisplatin—urinary bladder cancer	0.000783	0.00261	CcSEcCtD
Pethidine—Coma—Doxorubicin—urinary bladder cancer	0.000778	0.00259	CcSEcCtD
Pethidine—Anorexia—Thiotepa—urinary bladder cancer	0.000777	0.00259	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—urinary bladder cancer	0.000775	0.00258	CcSEcCtD
Pethidine—Flushing—Etoposide—urinary bladder cancer	0.000765	0.00254	CcSEcCtD
Pethidine—Visual disturbance—Methotrexate—urinary bladder cancer	0.000753	0.00251	CcSEcCtD
Pethidine—Muscle spasms—Cisplatin—urinary bladder cancer	0.000753	0.00251	CcSEcCtD
Pethidine—Tremor—Cisplatin—urinary bladder cancer	0.000734	0.00244	CcSEcCtD
Pethidine—Hypertension—Gemcitabine—urinary bladder cancer	0.000726	0.00241	CcSEcCtD
Pethidine—Somnolence—Thiotepa—urinary bladder cancer	0.000725	0.00241	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—urinary bladder cancer	0.000717	0.00239	CcSEcCtD
Pethidine—Convulsion—Fluorouracil—urinary bladder cancer	0.000716	0.00238	CcSEcCtD
Pethidine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000709	0.00236	CcSEcCtD
Pethidine—Constipation—Thiotepa—urinary bladder cancer	0.000697	0.00232	CcSEcCtD
Pethidine—SLC6A2—female reproductive system—urinary bladder cancer	0.000697	0.027	CbGeAlD
Pethidine—Muscle spasms—Etoposide—urinary bladder cancer	0.00069	0.00229	CcSEcCtD
Pethidine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000686	0.00228	CcSEcCtD
Pethidine—Oedema—Gemcitabine—urinary bladder cancer	0.000686	0.00228	CcSEcCtD
Pethidine—Irritability—Methotrexate—urinary bladder cancer	0.000681	0.00227	CcSEcCtD
Pethidine—Confusional state—Fluorouracil—urinary bladder cancer	0.00068	0.00226	CcSEcCtD
Pethidine—Convulsion—Cisplatin—urinary bladder cancer	0.000679	0.00226	CcSEcCtD
Pethidine—Mood swings—Methotrexate—urinary bladder cancer	0.000676	0.00225	CcSEcCtD
Pethidine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000674	0.00224	CcSEcCtD
Pethidine—Oedema—Fluorouracil—urinary bladder cancer	0.000674	0.00224	CcSEcCtD
Pethidine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000672	0.00223	CcSEcCtD
Pethidine—Anxiety—Cisplatin—urinary bladder cancer	0.000665	0.00221	CcSEcCtD
Pethidine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000663	0.00221	CcSEcCtD
Pethidine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000658	0.00219	CcSEcCtD
Pethidine—Affect lability—Epirubicin—urinary bladder cancer	0.000657	0.00219	CcSEcCtD
Pethidine—Anorexia—Gemcitabine—urinary bladder cancer	0.000654	0.00217	CcSEcCtD
Pethidine—Urticaria—Thiotepa—urinary bladder cancer	0.000648	0.00215	CcSEcCtD
Pethidine—Vertigo—Etoposide—urinary bladder cancer	0.000645	0.00214	CcSEcCtD
Pethidine—Anorexia—Fluorouracil—urinary bladder cancer	0.000643	0.00214	CcSEcCtD
Pethidine—CYP2B6—renal system—urinary bladder cancer	0.000641	0.0248	CbGeAlD
Pethidine—Hypotension—Gemcitabine—urinary bladder cancer	0.000641	0.00213	CcSEcCtD
Pethidine—Oedema—Cisplatin—urinary bladder cancer	0.000639	0.00213	CcSEcCtD
Pethidine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000639	0.00213	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000635	0.00211	CcSEcCtD
Pethidine—Mood swings—Epirubicin—urinary bladder cancer	0.000633	0.0021	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000631	0.0021	CcSEcCtD
Pethidine—Hypotension—Fluorouracil—urinary bladder cancer	0.00063	0.0021	CcSEcCtD
Pethidine—Tachycardia—Cisplatin—urinary bladder cancer	0.000624	0.00208	CcSEcCtD
Pethidine—Convulsion—Etoposide—urinary bladder cancer	0.000622	0.00207	CcSEcCtD
Pethidine—Insomnia—Gemcitabine—urinary bladder cancer	0.00062	0.00206	CcSEcCtD
Pethidine—Hypertension—Etoposide—urinary bladder cancer	0.00062	0.00206	CcSEcCtD
Pethidine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000618	0.00206	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00061	0.00203	CcSEcCtD
Pethidine—Insomnia—Fluorouracil—urinary bladder cancer	0.00061	0.00203	CcSEcCtD
Pethidine—Somnolence—Gemcitabine—urinary bladder cancer	0.00061	0.00203	CcSEcCtD
Pethidine—Anorexia—Cisplatin—urinary bladder cancer	0.000609	0.00203	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—urinary bladder cancer	0.000608	0.00202	CcSEcCtD
Pethidine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000601	0.002	CcSEcCtD
Pethidine—Somnolence—Fluorouracil—urinary bladder cancer	0.0006	0.00199	CcSEcCtD
Pethidine—Hypotension—Cisplatin—urinary bladder cancer	0.000597	0.00199	CcSEcCtD
Pethidine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000596	0.00198	CcSEcCtD
Pethidine—CYP2C19—vagina—urinary bladder cancer	0.000593	0.023	CbGeAlD
Pethidine—Confusional state—Etoposide—urinary bladder cancer	0.000591	0.00196	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000588	0.00195	CcSEcCtD
Pethidine—Constipation—Gemcitabine—urinary bladder cancer	0.000587	0.00195	CcSEcCtD
Pethidine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000586	0.00195	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000586	0.00195	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—urinary bladder cancer	0.000586	0.00195	CcSEcCtD
Pethidine—Asthenia—Thiotepa—urinary bladder cancer	0.000585	0.00195	CcSEcCtD
Pethidine—Pruritus—Thiotepa—urinary bladder cancer	0.000577	0.00192	CcSEcCtD
Pethidine—Tachycardia—Etoposide—urinary bladder cancer	0.000572	0.0019	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000566	0.00188	CcSEcCtD
Pethidine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000565	0.00188	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000565	0.00188	CcSEcCtD
Pethidine—Anorexia—Etoposide—urinary bladder cancer	0.000558	0.00186	CcSEcCtD
Pethidine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000556	0.00185	CcSEcCtD
Pethidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000556	0.00185	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—urinary bladder cancer	0.00055	0.00183	CcSEcCtD
Pethidine—Hypotension—Etoposide—urinary bladder cancer	0.000547	0.00182	CcSEcCtD
Pethidine—ORM1—lymph node—urinary bladder cancer	0.000543	0.021	CbGeAlD
Pethidine—Dizziness—Thiotepa—urinary bladder cancer	0.000539	0.00179	CcSEcCtD
Pethidine—Urticaria—Fluorouracil—urinary bladder cancer	0.000536	0.00178	CcSEcCtD
Pethidine—Sweating—Methotrexate—urinary bladder cancer	0.000527	0.00175	CcSEcCtD
Pethidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000527	0.00175	CcSEcCtD
Pethidine—Somnolence—Etoposide—urinary bladder cancer	0.000521	0.00173	CcSEcCtD
Pethidine—Vomiting—Thiotepa—urinary bladder cancer	0.000518	0.00172	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—urinary bladder cancer	0.000515	0.00171	CcSEcCtD
Pethidine—Rash—Thiotepa—urinary bladder cancer	0.000514	0.00171	CcSEcCtD
Pethidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000514	0.00171	CcSEcCtD
Pethidine—CYP2B6—female reproductive system—urinary bladder cancer	0.000514	0.0199	CbGeAlD
Pethidine—Headache—Thiotepa—urinary bladder cancer	0.000511	0.0017	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—urinary bladder cancer	0.000509	0.00169	CcSEcCtD
Pethidine—Constipation—Etoposide—urinary bladder cancer	0.000501	0.00167	CcSEcCtD
Pethidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000497	0.00165	CcSEcCtD
Pethidine—Sweating—Epirubicin—urinary bladder cancer	0.000493	0.00164	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000492	0.00164	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000485	0.00161	CcSEcCtD
Pethidine—Nausea—Thiotepa—urinary bladder cancer	0.000484	0.00161	CcSEcCtD
Pethidine—CYP3A4—renal system—urinary bladder cancer	0.000484	0.0187	CbGeAlD
Pethidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000483	0.00161	CcSEcCtD
Pethidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000477	0.00159	CcSEcCtD
Pethidine—ALB—lymph node—urinary bladder cancer	0.000477	0.0184	CbGeAlD
Pethidine—CYP2D6—renal system—urinary bladder cancer	0.000476	0.0184	CbGeAlD
Pethidine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000476	0.00158	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—urinary bladder cancer	0.000476	0.00158	CcSEcCtD
Pethidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000471	0.00157	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—urinary bladder cancer	0.00047	0.00156	CcSEcCtD
Pethidine—Urticaria—Etoposide—urinary bladder cancer	0.000465	0.00155	CcSEcCtD
Pethidine—CYP2B6—vagina—urinary bladder cancer	0.000464	0.018	CbGeAlD
Pethidine—Asthenia—Cisplatin—urinary bladder cancer	0.000459	0.00153	CcSEcCtD
Pethidine—Sweating—Doxorubicin—urinary bladder cancer	0.000457	0.00152	CcSEcCtD
Pethidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000446	0.00148	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—urinary bladder cancer	0.000445	0.00148	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000436	0.00145	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000435	0.00145	CcSEcCtD
Pethidine—Rash—Gemcitabine—urinary bladder cancer	0.000432	0.00144	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000432	0.00144	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000432	0.00144	CcSEcCtD
Pethidine—Erythema—Methotrexate—urinary bladder cancer	0.00043	0.00143	CcSEcCtD
Pethidine—Headache—Gemcitabine—urinary bladder cancer	0.00043	0.00143	CcSEcCtD
Pethidine—Flushing—Epirubicin—urinary bladder cancer	0.000429	0.00143	CcSEcCtD
Pethidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000429	0.00143	CcSEcCtD
Pethidine—Rash—Fluorouracil—urinary bladder cancer	0.000425	0.00141	CcSEcCtD
Pethidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000425	0.00141	CcSEcCtD
Pethidine—Headache—Fluorouracil—urinary bladder cancer	0.000422	0.00141	CcSEcCtD
Pethidine—Asthenia—Etoposide—urinary bladder cancer	0.00042	0.0014	CcSEcCtD
Pethidine—Pruritus—Etoposide—urinary bladder cancer	0.000414	0.00138	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000412	0.00137	CcSEcCtD
Pethidine—SLC6A2—lymph node—urinary bladder cancer	0.000408	0.0158	CbGeAlD
Pethidine—Nausea—Gemcitabine—urinary bladder cancer	0.000407	0.00136	CcSEcCtD
Pethidine—Vomiting—Cisplatin—urinary bladder cancer	0.000406	0.00135	CcSEcCtD
Pethidine—Rash—Cisplatin—urinary bladder cancer	0.000403	0.00134	CcSEcCtD
Pethidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000403	0.00134	CcSEcCtD
Pethidine—Erythema—Epirubicin—urinary bladder cancer	0.000402	0.00134	CcSEcCtD
Pethidine—Nausea—Fluorouracil—urinary bladder cancer	0.000401	0.00133	CcSEcCtD
Pethidine—Flushing—Doxorubicin—urinary bladder cancer	0.000397	0.00132	CcSEcCtD
Pethidine—CYP3A4—female reproductive system—urinary bladder cancer	0.000388	0.015	CbGeAlD
Pethidine—Dizziness—Etoposide—urinary bladder cancer	0.000387	0.00129	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000387	0.00129	CcSEcCtD
Pethidine—Vertigo—Methotrexate—urinary bladder cancer	0.000386	0.00128	CcSEcCtD
Pethidine—CYP2D6—female reproductive system—urinary bladder cancer	0.000382	0.0148	CbGeAlD
Pethidine—Nausea—Cisplatin—urinary bladder cancer	0.00038	0.00126	CcSEcCtD
Pethidine—Convulsion—Methotrexate—urinary bladder cancer	0.000372	0.00124	CcSEcCtD
Pethidine—Vomiting—Etoposide—urinary bladder cancer	0.000372	0.00124	CcSEcCtD
Pethidine—Erythema—Doxorubicin—urinary bladder cancer	0.000372	0.00124	CcSEcCtD
Pethidine—Agitation—Epirubicin—urinary bladder cancer	0.00037	0.00123	CcSEcCtD
Pethidine—Rash—Etoposide—urinary bladder cancer	0.000369	0.00123	CcSEcCtD
Pethidine—Dermatitis—Etoposide—urinary bladder cancer	0.000369	0.00123	CcSEcCtD
Pethidine—Headache—Etoposide—urinary bladder cancer	0.000367	0.00122	CcSEcCtD
Pethidine—Vertigo—Epirubicin—urinary bladder cancer	0.000361	0.0012	CcSEcCtD
Pethidine—Syncope—Epirubicin—urinary bladder cancer	0.000361	0.0012	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000358	0.00119	CcSEcCtD
Pethidine—Palpitations—Epirubicin—urinary bladder cancer	0.000355	0.00118	CcSEcCtD
Pethidine—Confusional state—Methotrexate—urinary bladder cancer	0.000354	0.00118	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000354	0.00118	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000351	0.00117	CcSEcCtD
Pethidine—Convulsion—Epirubicin—urinary bladder cancer	0.000349	0.00116	CcSEcCtD
Pethidine—Nausea—Etoposide—urinary bladder cancer	0.000348	0.00116	CcSEcCtD
Pethidine—Hypertension—Epirubicin—urinary bladder cancer	0.000347	0.00116	CcSEcCtD
Pethidine—Agitation—Doxorubicin—urinary bladder cancer	0.000342	0.00114	CcSEcCtD
Pethidine—Anxiety—Epirubicin—urinary bladder cancer	0.000341	0.00114	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000339	0.00113	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—urinary bladder cancer	0.000335	0.00111	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—urinary bladder cancer	0.000334	0.00111	CcSEcCtD
Pethidine—Anorexia—Methotrexate—urinary bladder cancer	0.000334	0.00111	CcSEcCtD
Pethidine—Syncope—Doxorubicin—urinary bladder cancer	0.000334	0.00111	CcSEcCtD
Pethidine—Confusional state—Epirubicin—urinary bladder cancer	0.000331	0.0011	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—urinary bladder cancer	0.000329	0.00109	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000328	0.00109	CcSEcCtD
Pethidine—Oedema—Epirubicin—urinary bladder cancer	0.000328	0.00109	CcSEcCtD
Pethidine—Hypotension—Methotrexate—urinary bladder cancer	0.000328	0.00109	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000327	0.00109	CcSEcCtD
Pethidine—Shock—Epirubicin—urinary bladder cancer	0.000323	0.00107	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—urinary bladder cancer	0.000322	0.00107	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—urinary bladder cancer	0.000321	0.00107	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—urinary bladder cancer	0.00032	0.00107	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000317	0.00106	CcSEcCtD
Pethidine—Insomnia—Methotrexate—urinary bladder cancer	0.000317	0.00106	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000316	0.00105	CcSEcCtD
Pethidine—Anorexia—Epirubicin—urinary bladder cancer	0.000313	0.00104	CcSEcCtD
Pethidine—Somnolence—Methotrexate—urinary bladder cancer	0.000312	0.00104	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00031	0.00103	CcSEcCtD
Pethidine—Hypotension—Epirubicin—urinary bladder cancer	0.000307	0.00102	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000306	0.00102	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000305	0.00101	CcSEcCtD
Pethidine—Oedema—Doxorubicin—urinary bladder cancer	0.000304	0.00101	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000304	0.00101	CcSEcCtD
Pethidine—Shock—Doxorubicin—urinary bladder cancer	0.000299	0.000994	CcSEcCtD
Pethidine—Insomnia—Epirubicin—urinary bladder cancer	0.000297	0.000988	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000296	0.000986	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000294	0.000977	CcSEcCtD
Pethidine—Somnolence—Epirubicin—urinary bladder cancer	0.000292	0.000971	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—urinary bladder cancer	0.00029	0.000963	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000289	0.000962	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000285	0.000949	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—urinary bladder cancer	0.000284	0.000944	CcSEcCtD
Pethidine—Constipation—Epirubicin—urinary bladder cancer	0.000281	0.000934	CcSEcCtD
Pethidine—Urticaria—Methotrexate—urinary bladder cancer	0.000279	0.000927	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—urinary bladder cancer	0.000275	0.000914	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000271	0.0009	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—urinary bladder cancer	0.00027	0.000898	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000264	0.000878	CcSEcCtD
Pethidine—Urticaria—Epirubicin—urinary bladder cancer	0.000261	0.000868	CcSEcCtD
Pethidine—Constipation—Doxorubicin—urinary bladder cancer	0.00026	0.000864	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000258	0.00086	CcSEcCtD
Pethidine—Asthenia—Methotrexate—urinary bladder cancer	0.000252	0.000837	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00025	0.000833	CcSEcCtD
Pethidine—Pruritus—Methotrexate—urinary bladder cancer	0.000248	0.000826	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000242	0.000805	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—urinary bladder cancer	0.000241	0.000803	CcSEcCtD
Pethidine—Asthenia—Epirubicin—urinary bladder cancer	0.000236	0.000784	CcSEcCtD
Pethidine—Pruritus—Epirubicin—urinary bladder cancer	0.000232	0.000773	CcSEcCtD
Pethidine—Dizziness—Methotrexate—urinary bladder cancer	0.000232	0.000772	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000224	0.000744	CcSEcCtD
Pethidine—Vomiting—Methotrexate—urinary bladder cancer	0.000223	0.000742	CcSEcCtD
Pethidine—Rash—Methotrexate—urinary bladder cancer	0.000221	0.000736	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000221	0.000735	CcSEcCtD
Pethidine—Headache—Methotrexate—urinary bladder cancer	0.00022	0.000731	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000218	0.000725	CcSEcCtD
Pethidine—Dizziness—Epirubicin—urinary bladder cancer	0.000217	0.000722	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000215	0.000715	CcSEcCtD
Pethidine—Vomiting—Epirubicin—urinary bladder cancer	0.000209	0.000694	CcSEcCtD
Pethidine—Nausea—Methotrexate—urinary bladder cancer	0.000208	0.000693	CcSEcCtD
Pethidine—Rash—Epirubicin—urinary bladder cancer	0.000207	0.000689	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000207	0.000688	CcSEcCtD
Pethidine—Headache—Epirubicin—urinary bladder cancer	0.000206	0.000684	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000201	0.000668	CcSEcCtD
Pethidine—Nausea—Epirubicin—urinary bladder cancer	0.000195	0.000649	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—urinary bladder cancer	0.000193	0.000642	CcSEcCtD
Pethidine—Rash—Doxorubicin—urinary bladder cancer	0.000192	0.000637	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000191	0.000637	CcSEcCtD
Pethidine—Headache—Doxorubicin—urinary bladder cancer	0.00019	0.000633	CcSEcCtD
Pethidine—Nausea—Doxorubicin—urinary bladder cancer	0.00018	0.0006	CcSEcCtD
Pethidine—ALB—Metabolism—NAT1—urinary bladder cancer	7.23e-05	0.000535	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EP300—urinary bladder cancer	7.11e-05	0.000527	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.11e-05	0.000527	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	7.07e-05	0.000524	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EP300—urinary bladder cancer	6.93e-05	0.000514	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—SRC—urinary bladder cancer	6.92e-05	0.000512	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	6.84e-05	0.000507	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	6.84e-05	0.000507	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—HRAS—urinary bladder cancer	6.82e-05	0.000505	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—SRC—urinary bladder cancer	6.74e-05	0.0005	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.72e-05	0.000498	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	6.68e-05	0.000495	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—HRAS—urinary bladder cancer	6.65e-05	0.000493	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.63e-05	0.000491	CbGpPWpGaD
Pethidine—ALB—Metabolism—UGT2B7—urinary bladder cancer	6.61e-05	0.00049	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL8—urinary bladder cancer	6.52e-05	0.000483	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	6.51e-05	0.000482	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	6.49e-05	0.000481	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	6.49e-05	0.000481	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.38e-05	0.000473	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	6.36e-05	0.000471	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	6.29e-05	0.000466	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.17e-05	0.000457	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.14e-05	0.000455	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.09e-05	0.000451	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—EGFR—urinary bladder cancer	6.06e-05	0.000449	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.97e-05	0.000442	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.97e-05	0.000442	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP4B1—urinary bladder cancer	5.95e-05	0.000441	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	5.93e-05	0.00044	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—EGFR—urinary bladder cancer	5.91e-05	0.000438	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	5.83e-05	0.000432	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TNF—urinary bladder cancer	5.77e-05	0.000428	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.73e-05	0.000425	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—KRAS—urinary bladder cancer	5.73e-05	0.000424	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.72e-05	0.000424	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IFNA2—urinary bladder cancer	5.67e-05	0.00042	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—urinary bladder cancer	5.63e-05	0.000417	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC19A1—urinary bladder cancer	5.62e-05	0.000416	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—KRAS—urinary bladder cancer	5.58e-05	0.000414	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RBX1—urinary bladder cancer	5.55e-05	0.000411	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	5.51e-05	0.000408	CbGpPWpGaD
Pethidine—ALB—Metabolism—PRSS3—urinary bladder cancer	5.48e-05	0.000406	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.46e-05	0.000404	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	5.34e-05	0.000396	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TSC1—urinary bladder cancer	5.21e-05	0.000386	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMP—urinary bladder cancer	5.2e-05	0.000385	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.07e-05	0.000375	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	5.05e-05	0.000374	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	4.96e-05	0.000368	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	4.92e-05	0.000364	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.91e-05	0.000364	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	4.89e-05	0.000362	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—urinary bladder cancer	4.87e-05	0.000361	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—urinary bladder cancer	4.75e-05	0.000352	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.7e-05	0.000349	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	4.69e-05	0.000347	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.64e-05	0.000344	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.52e-05	0.000335	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	4.41e-05	0.000326	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—urinary bladder cancer	4.39e-05	0.000325	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.39e-05	0.000325	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMP—urinary bladder cancer	4.38e-05	0.000324	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	4.27e-05	0.000316	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.21e-05	0.000312	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	4.2e-05	0.000311	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	4.19e-05	0.000311	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.12e-05	0.000305	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—RRM2—urinary bladder cancer	4.06e-05	0.000301	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PLAU—urinary bladder cancer	4.03e-05	0.000298	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	4.02e-05	0.000298	CbGpPWpGaD
Pethidine—ALB—Metabolism—NAT2—urinary bladder cancer	3.96e-05	0.000293	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.94e-05	0.000292	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	3.93e-05	0.000291	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.9e-05	0.000289	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.9e-05	0.000289	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	3.81e-05	0.000282	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.78e-05	0.00028	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.76e-05	0.000279	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.76e-05	0.000279	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.68e-05	0.000273	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.65e-05	0.00027	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.62e-05	0.000268	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	3.61e-05	0.000268	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.57e-05	0.000264	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	3.55e-05	0.000263	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	3.55e-05	0.000263	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	3.52e-05	0.000261	CbGpPWpGaD
Pethidine—ALB—Metabolism—RRM2—urinary bladder cancer	3.42e-05	0.000253	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	3.4e-05	0.000252	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	3.34e-05	0.000248	CbGpPWpGaD
Pethidine—ALB—Hemostasis—CREBBP—urinary bladder cancer	3.32e-05	0.000246	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IGF1—urinary bladder cancer	3.28e-05	0.000243	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.27e-05	0.000242	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	3.22e-05	0.000239	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.21e-05	0.000238	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	3.2e-05	0.000237	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	3.19e-05	0.000236	CbGpPWpGaD
Pethidine—ALB—Metabolism—HPGDS—urinary bladder cancer	3.17e-05	0.000235	CbGpPWpGaD
Pethidine—ALB—Metabolism—ENO2—urinary bladder cancer	3.17e-05	0.000235	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.15e-05	0.000233	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.11e-05	0.000231	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTT1—urinary bladder cancer	3.07e-05	0.000227	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.07e-05	0.000227	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	3.05e-05	0.000226	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.03e-05	0.000225	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NQO1—urinary bladder cancer	3.03e-05	0.000225	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.02e-05	0.000224	CbGpPWpGaD
Pethidine—ALB—Hemostasis—RHOA—urinary bladder cancer	3e-05	0.000223	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	2.98e-05	0.00022	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.96e-05	0.000219	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	2.92e-05	0.000217	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.87e-05	0.000213	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	2.84e-05	0.000211	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	2.84e-05	0.000211	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	2.84e-05	0.00021	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	2.83e-05	0.000209	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.83e-05	0.000209	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.82e-05	0.000209	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	2.76e-05	0.000204	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.71e-05	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	2.7e-05	0.0002	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	2.69e-05	0.000199	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.61e-05	0.000194	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.61e-05	0.000194	CbGpPWpGaD
Pethidine—ALB—Metabolism—NQO1—urinary bladder cancer	2.55e-05	0.000189	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.54e-05	0.000188	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.53e-05	0.000187	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—urinary bladder cancer	2.52e-05	0.000187	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	2.49e-05	0.000184	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.48e-05	0.000183	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	2.47e-05	0.000183	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	2.46e-05	0.000182	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	2.44e-05	0.000181	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	2.4e-05	0.000178	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.36e-05	0.000175	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.35e-05	0.000174	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.32e-05	0.000172	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.32e-05	0.000172	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	2.31e-05	0.000171	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.29e-05	0.00017	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—urinary bladder cancer	2.26e-05	0.000168	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	2.25e-05	0.000167	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.22e-05	0.000165	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.22e-05	0.000165	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—urinary bladder cancer	2.2e-05	0.000163	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	2.18e-05	0.000162	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.16e-05	0.00016	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.14e-05	0.000158	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—urinary bladder cancer	2.13e-05	0.000158	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.11e-05	0.000156	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	2.1e-05	0.000156	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	2.08e-05	0.000154	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	2.08e-05	0.000154	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	2.07e-05	0.000153	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.06e-05	0.000153	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	2.05e-05	0.000152	CbGpPWpGaD
Pethidine—ALB—Metabolism—TYMS—urinary bladder cancer	1.98e-05	0.000147	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	1.98e-05	0.000146	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	1.96e-05	0.000145	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—urinary bladder cancer	1.96e-05	0.000145	CbGpPWpGaD
Pethidine—ALB—Metabolism—NCOR1—urinary bladder cancer	1.96e-05	0.000145	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	1.95e-05	0.000145	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.94e-05	0.000144	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.91e-05	0.000142	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	1.9e-05	0.000141	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	1.89e-05	0.00014	CbGpPWpGaD
Pethidine—ALB—Metabolism—GPX1—urinary bladder cancer	1.87e-05	0.000139	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.85e-05	0.000137	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.85e-05	0.000137	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	1.84e-05	0.000136	CbGpPWpGaD
Pethidine—ALB—Metabolism—ERCC2—urinary bladder cancer	1.84e-05	0.000136	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—urinary bladder cancer	1.82e-05	0.000135	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	1.79e-05	0.000132	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.78e-05	0.000132	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	1.78e-05	0.000132	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000132	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	1.76e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.76e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.00013	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.00013	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—urinary bladder cancer	1.73e-05	0.000128	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.71e-05	0.000127	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.71e-05	0.000127	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	1.69e-05	0.000126	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	1.68e-05	0.000125	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	1.67e-05	0.000124	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.67e-05	0.000123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	1.66e-05	0.000123	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.66e-05	0.000123	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	1.65e-05	0.000122	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	1.65e-05	0.000122	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.63e-05	0.000121	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—urinary bladder cancer	1.62e-05	0.00012	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.61e-05	0.00012	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.61e-05	0.00012	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.6e-05	0.000119	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	1.6e-05	0.000118	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	1.56e-05	0.000115	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.55e-05	0.000115	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—urinary bladder cancer	1.55e-05	0.000115	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.55e-05	0.000115	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.52e-05	0.000112	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	1.51e-05	0.000112	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.51e-05	0.000112	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	1.5e-05	0.000111	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	1.48e-05	0.000109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	1.44e-05	0.000107	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	1.43e-05	0.000106	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.43e-05	0.000106	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—urinary bladder cancer	1.4e-05	0.000104	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	1.39e-05	0.000103	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.38e-05	0.000102	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	1.36e-05	0.000101	CbGpPWpGaD
Pethidine—ALB—Metabolism—CREBBP—urinary bladder cancer	1.35e-05	9.98e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.31e-05	9.7e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.26e-05	9.32e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	1.25e-05	9.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	1.22e-05	9.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	1.21e-05	8.98e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	8.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	1.16e-05	8.59e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.16e-05	8.57e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.15e-05	8.54e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.15e-05	8.51e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.14e-05	8.46e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.11e-05	8.24e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTGS2—urinary bladder cancer	1.1e-05	8.17e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.09e-05	8.07e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.07e-05	7.91e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	7.82e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	7.82e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	1.02e-05	7.59e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.01e-05	7.49e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.93e-06	7.35e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	9.9e-06	7.33e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	9.8e-06	7.26e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—urinary bladder cancer	9.62e-06	7.12e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.33e-06	6.91e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—urinary bladder cancer	9.17e-06	6.79e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	9.1e-06	6.74e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	8.63e-06	6.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—urinary bladder cancer	8.23e-06	6.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.94e-06	5.88e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.57e-06	5.61e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.57e-06	5.61e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.27e-06	5.39e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.95e-06	4.41e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.19e-06	3.85e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.95e-06	3.67e-05	CbGpPWpGaD
